Dan Hartley - Genus Plc Group General Counsel and Company Secretary

GENSF Stock  USD 20.90  0.00  0.00%   

Executive

Mr. Dan Hartley serves as Group General Counsel Company Secretary of Genus PLC. He has significant experience in multijurisdictional patent litigation, mergers and acquisitions, patent licensing and managing product life cycles in complex areas. He holds degrees in science and law. Past Appointments Senior Vice President and International Counsel of Shire plc and senior and global roles in Australia, the UK and the US. since 2014.
Tenure 10 years
Phone44 1256 347 100
Webhttps://www.genusplc.com

Genus Plc Management Efficiency

The company has return on total asset (ROA) of 0.0379 % which means that it generated a profit of $0.0379 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0687 %, meaning that it generated $0.0687 on every $100 dollars invested by stockholders. Genus Plc's management efficiency ratios could be used to measure how well Genus Plc manages its routine affairs as well as how well it operates its assets and liabilities.
Genus plc has accumulated 182.1 M in total debt with debt to equity ratio (D/E) of 0.39, which is about average as compared to similar companies. Genus plc has a current ratio of 1.67, which is within standard range for the sector. Debt can assist Genus Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Genus Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genus plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genus to invest in growth at high rates of return. When we think about Genus Plc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

EXECUTIVE Age

Yan MBAAdagene
49
Ami KnoeflerAdagene
N/A
Xiaohong SheAdagene
57
Ling ZhouAdagene
N/A
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom. Genus Plc operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3500 people. Genus plc [GENSF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Genus plc Leadership Team

Elected by the shareholders, the Genus Plc's board of directors comprises two types of representatives: Genus Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genus. The board's role is to monitor Genus Plc's management team and ensure that shareholders' interests are well served. Genus Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genus Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alison Henriksen, CFO Director
Dan Hartley, Group General Counsel and Company Secretary
Nate Zwald, COO, Genus ABS Dairy
Elena Rice, Head Officer
Angelle Rosata, Group Human Resources Director
Jerry Thompson, COO, Genus Asia
Stephen Wilson, Group Fin. Director and Director
William Christianson, Chief Officer
Janet Duane, Group Controller

Genus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Genus Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Genus Pink Sheet

Genus Plc financial ratios help investors to determine whether Genus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genus with respect to the benefits of owning Genus Plc security.